YEX006 - A PRIVATE PROVIDER’S VIEW ON NIPT.
Non-invasive prenatal screening (NIPT) is available in the form of the IONA® test and IONA® Care from Yourgene Health’s Genomic Services laboratory in Manchester, UK. The test requires a maternal blood sample from the 10th week of gestation and uses next generation sequencing to determine the likelihood that the pregnancy is affected by trisomy 21, 18 or 13. In countries where it is permitted, the test can also offer fetal sex determination. IONA® Care offers additional analysis for Autosomal Aneuploidies (AA’s) and Sex Chromosome Aneuploidies (SCA’s).
Yourgene recently spoke with Helen Stanley to learn more about her views on NIPT and its future. Helen is a senior midwife with over 20 years of NHS experience. Helen also owns and operates The Midwife Company, a private provider of maternity care. The IONA® test is the primary service provided by The Midwife Company, particularly during the COVID-19 pandemic.